Jubilant Therapeutics appoints Luca Rastelli as Chief Scientific Officer EP News Bureau Mar 9, 2021 Dr Rastelli will lead all aspects of R&D for Jubilant Therapeutics and serve as a scientific liaison for the company to…
Jubilant Therapeutics, The Wistar Institute to collaborate on COVID-19 research EP News Bureau Jan 15, 2021 To evaluate the activity of novel PAD4 inhibitors to reduce clinical severity of COVID-19
